0.23Open0.23Pre Close0 Volume11 Open Interest170.00Strike Price0.00Turnover0.00%IV106.49%PremiumAug 23, 2024Expiry Date0.00Intrinsic Value100Multiplier-2DDays to Expiry0.23Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma358.43Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Fomo Mofo : we all saw the webinar. for a company with 18 employees id say they are doing really well. let's hope the stock gods smile upon us on Monday with some official good news
Ken Griffin Charity2 : Why not provide the source? GeoVax Expands Rights Under NIH COVID-19 License to Include Mpox and Smallpox This press release was published 19 December 2023.
Geovax has been working on a covid vaccine for the past 4 years. There is still no approved covid vaccine, much less one for mpox.